Findings set the stage for further investigation of hSFRP2 mAb as a targeted therapy for triple-negative breast cancer.

Mice lacking the extracellular matrix protein tenascin-C showed a reduced ability to repair muscular damage compared to controls.

Researchers say this is the first combination therapy that targets two different cancer survival mechanism: PARP and WNT signaling.

NeuMap, the first single‑cell atlas of neutrophils, reveals conserved functional hubs across health, infection, and cancer, reshaping immunity.

The Center supports clients across the development and manufacturing of biologics, RNA therapeutics, vaccines, and cell and gene therapies.

While House, Senate thwarted 40% cut to agency’s budget, about half of the largest recipients of agency grants saw cuts ...

New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.

EMMI leverages “the largest global database of binding data” to generate small molecule drugs in new chemical space to tackle hard targets.

While there are several bacteria and viruses causing pneumonia, the research team looked specifically at Streptococcus pneumoniae.

For super-resolution microscopes, AI helps by restoring images from even noisy, low-fluorescence data. That capability helps ...

With the advent of AI-powered protein design tools, protein-based therapeutics may no longer be constrained by the limits imposed by natural selection.

Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.